428 related articles for article (PubMed ID: 8086178)
41. Impaired fibrinolysis in coronary artery disease.
Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
[TBL] [Abstract][Full Text] [Related]
42. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
Mehta P; Parker RI
J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
[TBL] [Abstract][Full Text] [Related]
43. Hemostatic alterations associated with supraceliac aortic cross-clamping.
Anagnostopoulos PV; Shepard AD; Pipinos II; Raman SB; Chaudhry PA; Mishima T; Morita H; Suzuki G
J Vasc Surg; 2002 Jan; 35(1):100-8. PubMed ID: 11802139
[TBL] [Abstract][Full Text] [Related]
44. Release of von Willebrand factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery.
Valen G; Blombäck M; Sellei P; Lindblom D; Vaage J
Thromb Res; 1994 Jan; 73(1):21-9. PubMed ID: 8178310
[TBL] [Abstract][Full Text] [Related]
45. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
[TBL] [Abstract][Full Text] [Related]
46. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
47. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
48. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
[TBL] [Abstract][Full Text] [Related]
49. Pacing-induced myocardial ischemia does not affect the endothelial release of coagulant and fibrinolytic factors into the coronary circulation.
Gössinger HD; Speiser W; Siostrzonek P; Jung M; Kyrle PA; Heistinger M; Lechner K; Mösslacher H
Clin Cardiol; 1991 Mar; 14(3):250-6. PubMed ID: 1707356
[TBL] [Abstract][Full Text] [Related]
50. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
Voss R; Matthias FR; Borkowski G; Reitz D
Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
[TBL] [Abstract][Full Text] [Related]
51. Activation of coagulation and fibrinolysis during cardiothoracic operations.
Hunt BJ; Parratt RN; Segal HC; Sheikh S; Kallis P; Yacoub M
Ann Thorac Surg; 1998 Mar; 65(3):712-8. PubMed ID: 9527200
[TBL] [Abstract][Full Text] [Related]
52. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
53. Changes in Coagulation and Fibrinolysis Systems During the Perioperative Period of Acute Type A Aortic Dissection.
Zhou C; Li Y; Yan Y; Feng D; Wei M; Wen J
Heart Surg Forum; 2021 Mar; 24(2):E223-E230. PubMed ID: 33798057
[TBL] [Abstract][Full Text] [Related]
54. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
55. Plasma t-PA/PAI-1 complex and blood coagulability in patients with coronary artery disease.
Yamauchi K; Suzuki T; Furumichi T; Saito H
Jpn Heart J; 1992 May; 33(3):351-8. PubMed ID: 1522691
[TBL] [Abstract][Full Text] [Related]
56. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
Daniel WC; Meidell RS; Hillis LD; Lange RA
Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
[TBL] [Abstract][Full Text] [Related]
57. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D
Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958
[TBL] [Abstract][Full Text] [Related]
58. Endothelial cell activation in cutaneous vasculitis.
Jurd KM; Stephens CJ; Black MM; Hunt BJ
Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
[TBL] [Abstract][Full Text] [Related]
59. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
[TBL] [Abstract][Full Text] [Related]
60. Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
Eisses MJ; Seidel K; Aldea GS; Chandler WL
Anesth Analg; 2004 May; 98(5):1208-16, table of contents. PubMed ID: 15105189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]